Effect of Oral Administration of a Herbarium Mixture (Guazuma Ulmifolia and Tecoma Stans) on Metabolic Profile in Type 2 Diabetic Patients

• Status: Completed
• Trial end date: 2011-05-31
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the effect of oral administration of herbarium mixture Guazuma ulmifolia (GU) and Tecoma stans (TS) on metabolic profile in type 2 diabetic patients.

• Phase: Phase 2/Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Centro Universitario de Ciencias de la Salud, Mexico
• Treatments: Magnesium Oxide

Criteria

Inclusion Criteria:

• Signing of letter of consent under written information.

• Men and women with serum glucose of ≥126 and <400 mg / dl and / or HbA1c ≥6.5% and <10%.

• Age between 30 and 60 years.

• BMI between 25 - 39.9 kg / m2.

• With or without pharmacological treatment with oral hypoglycemic agents or insulin

• Stable body weight during the last 3 months (± 5%).

• Women in the follicular phase of the menstrual cycle (days 3 to 8 of the cycle) at the time of the laboratory tests

• Women who do not expect to be pregnant within the next 3 months.

Exclusion Criteria:

• Physical or mental incapacity that makes it impossible to carry out the intervention.

• Uncontrolled thyroid disease

• Women with suspicion or confirmation of pregnancy.

• Women who are breastfeeding.

• Hepatic disease or elevation to double the upper normal value of TGO and TGP.

• Diagnosis of renal insufficiency or creatinine> 1.5 mg / dL or glomerular filtration rate <60 mL / min).

• Known hypersensitivity to calcined magnesia or Guazuma ulmifolia and / or Tecoma stans.